Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 40

1.

Mouse tetherin enhances moloney murine leukemia virus-induced syncytium formation.

Kim HS, Han SY, Jung YT.

Acta Virol. 2016;60(4):372-378.

PMID:
27928916
2.

Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

Londrigan SL, Tate MD, Job ER, Moffat JM, Wakim LM, Gonelli CA, Purcell DF, Brooks AG, Villadangos JA, Reading PC, Mintern JD.

PLoS One. 2015 Nov 13;10(11):e0142925. doi: 10.1371/journal.pone.0142925. eCollection 2015.

3.

Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge.

Holmgren AM, Miller KD, Cavanaugh SE, Rall GF.

J Virol. 2015 Nov;89(21):11011-8. doi: 10.1128/JVI.01745-15. Epub 2015 Aug 26.

4.

Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection.

Mahauad-Fernandez WD, Jones PH, Okeoma CM.

J Gen Virol. 2014 Nov;95(Pt 11):2450-61. doi: 10.1099/vir.0.068643-0. Epub 2014 Jul 22.

5.

Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Li SX, Barrett BS, Heilman KJ, Messer RJ, Liberatore RA, Bieniasz PD, Kassiotis G, Hasenkrug KJ, Santiago ML.

J Immunol. 2014 Jul 1;193(1):306-16. doi: 10.4049/jimmunol.1400490. Epub 2014 May 28.

6.

BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.

Jones PH, Mahauad-Fernandez WD, Madison MN, Okeoma CM.

Virology. 2013 Sep;444(1-2):124-39. doi: 10.1016/j.virol.2013.05.042. Epub 2013 Jun 25.

7.

BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells.

Yi EH, Yoo H, Noh KH, Han S, Lee H, Lee JK, Won C, Kim BH, Kim MH, Cho CH, Ye SK.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):685-90. doi: 10.1016/j.bbrc.2013.05.043. Epub 2013 May 20.

PMID:
23702480
8.

A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo.

Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, Santiago ML.

PLoS Pathog. 2012;8(3):e1002596. doi: 10.1371/journal.ppat.1002596. Epub 2012 Mar 22.

9.

Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection.

Swiecki M, Wang Y, Gilfillan S, Lenschow DJ, Colonna M.

J Immunol. 2012 Mar 15;188(6):2488-92. doi: 10.4049/jimmunol.1103145. Epub 2012 Feb 10.

10.

Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo.

Liberatore RA, Bieniasz PD.

Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18097-101. doi: 10.1073/pnas.1113694108. Epub 2011 Oct 24.

11.

Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity.

Loschko J, Schlitzer A, Dudziak D, Drexler I, Sandholzer N, Bourquin C, Reindl W, Krug AB.

J Immunol. 2011 Jun 15;186(12):6718-25. doi: 10.4049/jimmunol.1004029. Epub 2011 May 9.

12.

In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.

Schliemann C, Roesli C, Kamada H, Borgia B, Fugmann T, Klapper W, Neri D.

Blood. 2010 Jan 21;115(3):736-44. doi: 10.1182/blood-2009-08-239004. Epub 2009 Nov 10.

13.

Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.

Li SX, Barrett BS, Guo K, Kassiotis G, Hasenkrug KJ, Dittmer U, Gibbert K, Santiago ML.

Sci Rep. 2016 Feb 5;6:20425. doi: 10.1038/srep20425.

14.

A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin.

Royer DJ, Carr DJ.

Mucosal Immunol. 2016 Jul;9(4):1065-75. doi: 10.1038/mi.2015.124. Epub 2015 Dec 2.

15.

Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.

Mahauad-Fernandez WD, DeMali KA, Olivier AK, Okeoma CM.

Breast Cancer Res. 2014 Dec 13;16(6):493. doi: 10.1186/s13058-014-0493-8.

16.

Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation.

Moffat JM, Segura E, Khoury G, Caminschi I, Cameron PU, Lewin SR, Villadangos JA, Mintern JD.

Eur J Immunol. 2013 Mar;43(3):595-605. doi: 10.1002/eji.201242799. Epub 2013 Feb 6.

17.

Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo.

Jones PH, Mehta HV, Maric M, Roller RJ, Okeoma CM.

Retrovirology. 2012 Jan 27;9:10. doi: 10.1186/1742-4690-9-10.

18.

Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons.

Sarojini S, Theofanis T, Reiss CS.

DNA Cell Biol. 2011 Dec;30(12):965-74. doi: 10.1089/dna.2011.1384. Epub 2011 Sep 15.

19.

Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release.

Swiecki M, Scheaffer SM, Allaire M, Fremont DH, Colonna M, Brett TJ.

J Biol Chem. 2011 Jan 28;286(4):2987-97. doi: 10.1074/jbc.M110.190538. Epub 2010 Nov 17.

20.

Involvement of a Golgi-resident GPI-anchored protein in maintenance of the Golgi structure.

Li X, Kaloyanova D, van Eijk M, Eerland R, van der Goot G, Oorschot V, Klumperman J, Lottspeich F, Starkuviene V, Wieland FT, Helms JB.

Mol Biol Cell. 2007 Apr;18(4):1261-71. Epub 2007 Jan 24.

Supplemental Content

Support Center